Description
AVODART® treats and prevents the progression of Benign Prostatic Hyperplasia (BPH) by decreasing the size of the prostate, relieving symptoms, improving urinary flow and decreasing the risk of Acute Urinary Retention (AUR), as well as the need for related surgical interventions. with HPB.
AVODART®, administered in combination with the alpha-blocker tamsulosin, treats and prevents the progression of benign prostatic hyperplasia (BPH) by reducing the size of the prostate, relieving symptoms and improving urinary flow, and reducing the risk of develop acute urinary retention (AUR) and the need for BPH-related surgery (see Clinical Studies).






Reviews
There are no reviews yet.